Chemed Q4 2021 adj EPS $5.25, up 2.3%; VITAS revenue down 4.8%; issues mixed 2022 guidance

CHEMED CORP

2021-FY EPS reported $16.85 revenue$2,139,261,000

Consolidated Q4 revenue $541M (+1.4%); GAAP diluted EPS $4.81; adjusted diluted EPS $5.25 (+2.3%).
VITAS net revenue $316M (-4.8%), ADC 17,935 (-4.2%), admissions down 9.5%; adjusted EBITDA margin 21.7% (-179 bps).
Roto-Rooter revenue $225M (+11.8%); adjusted EBITDA $62.2M (+14.2%); margin 27.7% (+58 bps).
2022 guidance: adjusted EPS $19.10-$19.50 (vs 2021 $19.33); VITAS revenue down 1.5-2.5%; Roto-Rooter revenue growth 8-9.5%.
Q4 share repurchases: 495,529 shares for $246M; $202M remaining authorization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.